Cargando…
Pulmonary microRNA profiling: implications in upper lobe predominant lung disease
BACKGROUND: Numerous pulmonary diseases manifest with upper lobe predominance including cystic fibrosis, smoking-related chronic obstructive pulmonary disease, and tuberculosis. Zonal hypoxia, characteristic of these pulmonary maladies, and oxygen stress in general is known to exert profound effects...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450072/ https://www.ncbi.nlm.nih.gov/pubmed/28572860 http://dx.doi.org/10.1186/s13148-017-0355-1 |
_version_ | 1783239883433705472 |
---|---|
author | Armstrong, David A. Nymon, Amanda B. Ringelberg, Carol S. Lesseur, Corina Hazlett, Haley F. Howard, Louisa Marsit, Carmen J. Ashare, Alix |
author_facet | Armstrong, David A. Nymon, Amanda B. Ringelberg, Carol S. Lesseur, Corina Hazlett, Haley F. Howard, Louisa Marsit, Carmen J. Ashare, Alix |
author_sort | Armstrong, David A. |
collection | PubMed |
description | BACKGROUND: Numerous pulmonary diseases manifest with upper lobe predominance including cystic fibrosis, smoking-related chronic obstructive pulmonary disease, and tuberculosis. Zonal hypoxia, characteristic of these pulmonary maladies, and oxygen stress in general is known to exert profound effects on various important aspects of cell biology. Lung macrophages are major participants in the pulmonary innate immune response and regional differences in macrophage responsiveness to hypoxia may contribute in the development of lung disease. MicroRNAs are ubiquitous regulators of human biology and emerging evidence indicates altered microRNA expression modulates respiratory disease processes. The objective of this study is to gain insight into the epigenetic and cellular mechanisms influencing regional differences in lung disease by investigating effect of hypoxia on regional microRNA expression in the lung. All studies were performed using primary alveolar macrophages (n = 10) or bronchoalveolar lavage fluid (n = 16) isolated from human subjects. MicroRNA was assayed via the NanoString nCounter microRNA assay. RESULTS: Divergent molecular patterns of microRNA expression were observed in alternate lung lobes, specifically noted was disparate expression of miR-93 and miR-4454 in alveolar macrophages along with altered expression of miR-451a and miR-663a in bronchoalveolar lavage fluid. Gene ontology was used to identify potential downstream targets of divergent microRNAs. Targets include cytokines and matrix metalloproteinases, molecules that could have a significant impact on pulmonary inflammation and fibrosis. CONCLUSIONS: Our findings show variant regional microRNA expression associated with hypoxia in alveolar macrophages and BAL fluid in the lung—upper vs lower lobe. Future studies should address whether these specific microRNAs may act intracellularly, in a paracrine/endocrine manner to direct the innate immune response or may ultimately be involved in pulmonary host-to-pathogen trans-kingdom cross-talk. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-017-0355-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5450072 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54500722017-06-01 Pulmonary microRNA profiling: implications in upper lobe predominant lung disease Armstrong, David A. Nymon, Amanda B. Ringelberg, Carol S. Lesseur, Corina Hazlett, Haley F. Howard, Louisa Marsit, Carmen J. Ashare, Alix Clin Epigenetics Research BACKGROUND: Numerous pulmonary diseases manifest with upper lobe predominance including cystic fibrosis, smoking-related chronic obstructive pulmonary disease, and tuberculosis. Zonal hypoxia, characteristic of these pulmonary maladies, and oxygen stress in general is known to exert profound effects on various important aspects of cell biology. Lung macrophages are major participants in the pulmonary innate immune response and regional differences in macrophage responsiveness to hypoxia may contribute in the development of lung disease. MicroRNAs are ubiquitous regulators of human biology and emerging evidence indicates altered microRNA expression modulates respiratory disease processes. The objective of this study is to gain insight into the epigenetic and cellular mechanisms influencing regional differences in lung disease by investigating effect of hypoxia on regional microRNA expression in the lung. All studies were performed using primary alveolar macrophages (n = 10) or bronchoalveolar lavage fluid (n = 16) isolated from human subjects. MicroRNA was assayed via the NanoString nCounter microRNA assay. RESULTS: Divergent molecular patterns of microRNA expression were observed in alternate lung lobes, specifically noted was disparate expression of miR-93 and miR-4454 in alveolar macrophages along with altered expression of miR-451a and miR-663a in bronchoalveolar lavage fluid. Gene ontology was used to identify potential downstream targets of divergent microRNAs. Targets include cytokines and matrix metalloproteinases, molecules that could have a significant impact on pulmonary inflammation and fibrosis. CONCLUSIONS: Our findings show variant regional microRNA expression associated with hypoxia in alveolar macrophages and BAL fluid in the lung—upper vs lower lobe. Future studies should address whether these specific microRNAs may act intracellularly, in a paracrine/endocrine manner to direct the innate immune response or may ultimately be involved in pulmonary host-to-pathogen trans-kingdom cross-talk. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13148-017-0355-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-05-30 /pmc/articles/PMC5450072/ /pubmed/28572860 http://dx.doi.org/10.1186/s13148-017-0355-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Armstrong, David A. Nymon, Amanda B. Ringelberg, Carol S. Lesseur, Corina Hazlett, Haley F. Howard, Louisa Marsit, Carmen J. Ashare, Alix Pulmonary microRNA profiling: implications in upper lobe predominant lung disease |
title | Pulmonary microRNA profiling: implications in upper lobe predominant lung disease |
title_full | Pulmonary microRNA profiling: implications in upper lobe predominant lung disease |
title_fullStr | Pulmonary microRNA profiling: implications in upper lobe predominant lung disease |
title_full_unstemmed | Pulmonary microRNA profiling: implications in upper lobe predominant lung disease |
title_short | Pulmonary microRNA profiling: implications in upper lobe predominant lung disease |
title_sort | pulmonary microrna profiling: implications in upper lobe predominant lung disease |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450072/ https://www.ncbi.nlm.nih.gov/pubmed/28572860 http://dx.doi.org/10.1186/s13148-017-0355-1 |
work_keys_str_mv | AT armstrongdavida pulmonarymicrornaprofilingimplicationsinupperlobepredominantlungdisease AT nymonamandab pulmonarymicrornaprofilingimplicationsinupperlobepredominantlungdisease AT ringelbergcarols pulmonarymicrornaprofilingimplicationsinupperlobepredominantlungdisease AT lesseurcorina pulmonarymicrornaprofilingimplicationsinupperlobepredominantlungdisease AT hazletthaleyf pulmonarymicrornaprofilingimplicationsinupperlobepredominantlungdisease AT howardlouisa pulmonarymicrornaprofilingimplicationsinupperlobepredominantlungdisease AT marsitcarmenj pulmonarymicrornaprofilingimplicationsinupperlobepredominantlungdisease AT asharealix pulmonarymicrornaprofilingimplicationsinupperlobepredominantlungdisease |